Samalin Investment Counsel, LLC Novartis Ag Transaction History

Samalin Investment Counsel, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $2,818 - $3,281	-35 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $1,922 - $2,174	-24 Reduced 40.68%	35 $3.07 Million
Q2 2021 Aug 12, 2021	BUY	$85.24 - $94.15 $5,029 - $5,554	59 New	59 $5,000
Q1 2021 May 11, 2021	SELL	$83.5 - $98.47 $4,926 - $5,809	-59 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$82.14 - $91.0 $4,846 - $5,369	59 New	59 $5,000
Q1 2020 May 04, 2020	SELL	$70.67 - $99.01 $7,985 - $11,188	-113 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$84.35 - $95.37 $9,531 - $10,776	113 New	113 $10,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $228B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.